SPONSORED CONTENT
When people consider technology’s role in adapting to pandemic-constrained life, many begrudgingly think about endless hours spent on videoconferences. Yet, pandemic-infused technological innovations also altered our lives in other ways, big and small. For instance, I’ll never go back to
…SPONSORED CONTENT
Commencing in the early 1970s, specialty pharmacy was originally intended for patients requiring unique therapies for various conditions. Initially this included mainly infusions for hemophilia, cancer, or malnutrition[i]. Most of these offerings came with
…SPONSORED CONTENT
Location: Gaylord National Resort & Convention Center
Start your 340B Coalition Summer Conference with the latest developments in the 340B program. Verity Solutions will be hosting a panel discussion at the Gaylord Resort in National Harbor with some of the
…SPONSORED CONTENT
The healthcare industry continues to evolve. We see this evolution range from technology advancements and self-serve digital platforms to competing payer coverages and vast access to both acute and maintenance medications. Throughout this evolution, the patient experience and continuity of care
…
Publisher’s Note: Since we first published this piece by Jennifer Lockwood of Ravin Consultants, there has been an important development that is addressed at the end of the story. We thank Jennifer and her team for alerting us and recommending that we
…SPONSORED CONTENT
The 340B drug pricing program, which allows eligible healthcare providers known as covered entities to purchase medications at a reduced price, has been an incredibly valuable tool for providing affordable healthcare to underserved populations. However, the benefits of the 340B program
…SPONSORED CONTENT
Many people have been losing sleep thinking about how they should move forward in the current 340B environment. Over the last 18 months, it has felt like an external force is around every corner, pushing or pulling covered entities into new areas of discomfort.
…SPONSORED CONTENT
Many covered entities are not aware of the opportunity to capture referral prescriptions. This includes ones that were initially determined to be non-eligible by your TPA but after a closer look in your EMR are deemed to be eligible. Don’t miss out
…
SPONSORED CONTENT
Resolving 340B noncompliance can be a time-consuming task for 340B participants — and one of the greatest challenges in managing a 340B program. This guide outlines the five steps to successfully navigate resolving compliance issues requiring repayment to manufacturers, from discovery to resolution, and includes
…*Sign up for news summaries and alerts from 340B Report
